Trimel to Report Financial Results for 2013 and Host Conference Call to Update Investors
27 Febbraio 2014 - 10:45PM
Marketwired
Trimel to Report Financial Results for 2013 and Host Conference
Call to Update Investors
TORONTO, ONTARIO--(Marketwired - Feb 27, 2014) - Trimel
Pharmaceuticals Corporation (TSX:TRL) will report its financial
results for the 3 month and 12 month periods ended December 31,
2013 on Wednesday, March 5th 2014 after market close.
Management of the Company will host a conference call to discuss
these results and update investors on the status of its business on
Thursday, March 6th 2014, at 8:30 a.m. Eastern Standard Time.
Following the discussion, Trimel executives will address inquires
from investment analysts.
To access the call live, please dial 416-340-2216 or
1-866-223-7781. Listeners are encouraged to dial in 10 minutes
before the call begins to avoid delays.
A replay of the conference call will be available until 7:00
p.m. Eastern Standard Time on Thursday, March 13th, 2014 by dialing
905-694-9451 or 1-800-408-3053, using access code: 7051335#.
For further information regarding Trimel Pharmaceuticals
Corporation, please contact Kenneth Howling, Chief Financial
Officer at (416) 679-0536 or via email at
ir@trimelpharmaceuticals.com.
About Trimel
Trimel is a specialty pharmaceutical company actively developing
medications for male hypogonadism, female sexual dysfunction and
various respiratory disorders. An NDA for CompleoTRT™, a product
utilizing Trimel's licensed bioadhesive intranasal gel technology,
has been accepted for review by the FDA for regulatory approval in
the United States. For more information, please visit
www.trimelpharmaceuticals.com.
Trimel Pharmaceuticals CorporationKenneth G. HowlingChief
Financial Officer(416)
679-0536ir@trimelpharmaceuticals.comwww.trimelpharmaceuticals.com
Grafico Azioni Trilogy International Pa... (TSX:TRL)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Trilogy International Pa... (TSX:TRL)
Storico
Da Set 2023 a Set 2024
Notizie in Tempo Reale relative a Trilogy International Partners Inc (Borsa di Toronto (TSX)): 0 articoli recenti
Più Trimel Pharmaceuticals Corp Articoli Notizie